A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes
Clinical trial NCT04992312 · COMPLETED
Trial details
- NCT number
- NCT04992312
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-24
- Primary completion
- 2023-11-05
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.